Bringing a new life sciences facility online is no longer just a construction milestone — it is a knowledge milestone.  Most project delays do not come...

After startup, facilities drift into uncertainty as processes evolve and equipment ages. Digital twins restore visibility, reduce operational expenditure, and strengthen readiness by modeling, monitoring,...

Despite unprecedented data availability in biopharma manufacturing, decision-making remains slow and uncertain. This piece argues the constraint is data friction, and shows how reducing it...

Operational readiness isn’t a milestone. It’s a condition, a designed state that ensures your facility starts up safely, on time, on budget, and at the...

From CQV roots to a broader operational readiness model, CAI continues helping organizations navigate rising complexity and operate with confidence and speed in highly regulated...

When I founded Commissioning Agents in 1996, the practice of “validation” was a paperwork exercise that was ineffective at assuring equipment worked to meet stakeholder...

After startup, most facilities slowly return to uncertainty. Procedures evolve, equipment ages, and process behavior drifts. Teams spend increasing effort rediscovering system behavior through deviations...

Technology transfer (TT) in biopharmaceutical manufacturing is the structured process of transferring product and process knowledge from a Sending Unit (SU) to a Receiving Unit...

Written by Paige Kane, PhD, CPIP   If you work in Life Sciences, you know that it is a complex, high-stakes operation.  I’ve been through my...